BioLife Solutions, Inc. (BLFS)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

BioLife Solutions, Inc. (BLFS) is up 12.7% since the beginning of the year. At $27 per share, BLFS is trading 8.0% below its 52-week high of $30. Investors who bought $1,000 worth of BLFS shares 5 years ago would now be looking at an investment worth $827.

BioLife Solutions, Inc. (BLFS) has returned 12.70% so far this year and 27.46% over the past 12 months. Looking at the last ten years, BLFS has achieved an annualized return of 32.86%, outperforming the S&P 500 Index benchmark, which averaged 13.66% per year.

Based on dividend-adjusted daily data since May 26, 1992, BLFS's average daily return is +0.60%, while the average monthly return is +3.90%. At this rate, an investment would double in approximately 1.5 years.

Historically, 44% of months were positive and 56% were negative. The best month was Jun 2000 with a return of +463.3%, while the worst month was Oct 2000 at -56.0%. The longest winning streak lasted 6 consecutive months, and the longest losing streak was 8 months.

On a daily basis, BLFS closed higher 35% of trading days. The best single day was Jun 16, 2000 with a return of +358.5%, while the worst single day was Oct 12, 2011 at -71.4%.

BioLife Solutions, Inc. has an annualized alpha of 335.76%, beta of 0.46, and R2 of 0.00 versus S&P 500 Index. Calculated based on daily prices since May 27, 1992.

• This stock participated in 115.42% of S&P 500 Index downside but only 55.34% of its upside - more exposed to losses than it benefited from rallies.
• Beta of 0.46 may look defensive, but with R2 of 0.00 this stock is largely uncorrelated with S&P 500 Index - low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
• R2 of 0.00 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

BLFS ranks 58 for risk / return — on par with similar stocks. You're getting a typical balance of risk and reward. Not a standout, but not a red flag either — a reasonable choice if other factors align with your goals.

The table below present risk-adjusted performance metrics for BioLife Solutions, Inc. (BLFS) and compare them to S&P 500 Index.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the BioLife Solutions, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the BioLife Solutions, Inc. was 99.80%, occurring on Oct 15, 2008. The portfolio has not yet recovered.

The current BioLife Solutions, Inc. drawdown is 80.54%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of BioLife Solutions, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how BioLife Solutions, Inc. is priced in the market compared to other companies in the Medical Instruments & Supplies industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.